Compare FMC Corp (FMC) vs Nuscale Power Corporation (SMR) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

NuScale Power (SMR) trades at $7.54, down 12.22% in the last session amid ongoing operational challenges. The stock shows bearish technical signals with key support at $7.00. Fundamentally, the company reported a net loss of $355.79 million on $31.48 million revenue in 2025, with negative margins and cash burn from operations. Analyst consensus remains optimistic with a $12.25 price target despite recent earnings misses.

The investment case hinges on SMR's first-mover advantage in nuclear technology and potential AI-driven power demand, but faces significant execution risk. With no commercial reactors yet operational and substantial cash burn, the stock represents high-risk speculation. Current valuation appears stretched given negative profitability metrics and uncertain revenue timeline.